We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $106K | ﹤0.01% |
1,010
-173
| -15% | -$18.2K |
|
752
ProShares UltraPro Short S&P 500
SPXU
$436M
| $104K | ﹤0.01% |
120
-60
| -33% | -$56.4K |
|
753
Nokia
NOK
$50.8B
| $103K | ﹤0.01% |
26,468
| – | – |
|
754
Ovid Therapeutics
OVID
$435M
| $103K | ﹤0.01% |
18,000
| – | – |
|
755
GrafTech
EAF
$194M
| $102K | ﹤0.01% |
1,500
-17,640
| -92% | -$1.23M |
|
756
Mercado Libre
MELI
$91.3B
| $102K | ﹤0.01% |
95
+5
| +6% | +$5.42K |
|
757
Ventas
VTR
$48.9B
| $101K | ﹤0.01% |
2,422
-10
| -0.4% | -$400 |
|
758
Labcorp
LH
$24.3B
| $100K | ﹤0.01% |
624
| – | – |
|
759
iShares MSCI Emerging Markets ETF
EEM
$28B
| $99K | ﹤0.01% |
2,248
-422
| -16% | -$18.5K |
|
760
Tejon Ranch
TRC
$476M
| $99K | ﹤0.01% |
7,053
| – | – |
|
761
Hormel Foods
HRL
$13.9B
| $97K | ﹤0.01% |
2,000
| – | – |
|
762
T-Mobile US
TMUS
$193B
| $97K | ﹤0.01% |
850
+500
| +143% | +$55.4K |
|
763
Vistra
VST
$55.1B
| $94K | ﹤0.01% |
+5,000
| New | +$94.2K |
|
764
American States Water
AWR
$3.39B
| $93K | ﹤0.01% |
1,250
| – | – |
|
|
XEC
765
DELISTED
CIMAREX ENERGY CO
XEC
| $93K | ﹤0.01% |
3,825
| – | – |
|
|
HDV
766
iShares Core High Dividend ETF
HDV
$14.4B
| $92K | ﹤0.01% |
5,750
+3,065
| +114% | +$51K |
|
767
International Paper
IP
$22.3B
| $92K | ﹤0.01% |
2,402
+79
| +3% | +$2.79K |
|
768
BlackBerry
BB
$5.01B
| $91K | ﹤0.01% |
20,000
+7,900
| +65% | +$38.2K |
|
769
CVB Financial
CVBF
$3.98B
| $90K | ﹤0.01% |
5,442
| – | – |
|
770
LCI Industries
LCII
$2.51B
| $90K | ﹤0.01% |
850
-150
| -15% | -$17.5K |
|
771
U-Haul Holding Co
UHAL
$14B
| $90K | ﹤0.01% |
2,550
-300
| -11% | -$10.2K |
|
772
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.32B
| $88K | ﹤0.01% |
2,984
| – | – |
|
773
Synopsys
SNPS
$71.5B
| $87K | ﹤0.01% |
407
| – | – |
|
774
Teladoc Health
TDOC
$1.58B
| $86K | ﹤0.01% |
396
+326
| +466% | +$69K |
|
775
TransUnion
TRU
$14.8B
| $86K | ﹤0.01% |
1,025
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.